Accurate tissue motion tracking is critical to ensure treatment outcome and safety in 2D-Cine MRI-guided radiotherapy. This is typically achieved by registration of sequential images, but existing methods often face challenges with large misalignments and lack of interpretability. In this paper, we introduce DINOMotion, a novel deep learning framework based on DINOv2 with Low-Rank Adaptation (LoRA) layers for robust, efficient, and interpretable motion tracking. DINOMotion automatically detects corresponding landmarks to derive optimal image registration, enhancing interpretability by providing explicit visual correspondences between sequential images. The integration of LoRA layers reduces trainable parameters, improving training efficiency, while DINOv2's powerful feature representations offer robustness against large misalignments. Unlike iterative optimization-based methods, DINOMotion directly computes image registration at test time. Our experiments on volunteer and patient datasets demonstrate its effectiveness in estimating both linear and nonlinear transformations, achieving Dice scores of 92.07% for the kidney, 90.90% for the liver, and 95.23% for the lung, with corresponding Hausdorff distances of 5.47 mm, 8.31 mm, and 6.72 mm, respectively. DINOMotion processes each scan in approximately 30ms and consistently outperforms state-of-the-art methods, particularly in handling large misalignments. These results highlight its potential as a robust and interpretable solution for real-time motion tracking in 2D-Cine MRI-guided radiotherapy.

This study aimed to develop and validate deep learning models using [¹⁸F]FDG PET/CT to predict PD-L1 status in esophageal cancer (EC) patients. Additionally, we assessed the potential of derived deep learning model scores (DLS) for survival stratification in immunotherapy. In this retrospective study, we included 331 EC patients from two centers, dividing them into training, internal validation, and external validation cohorts. Fifty patients who received immunotherapy were followed up. We developed four 3D ResNet10-based models-PET + CT + clinical factors (CPC), PET + CT (PC), PET (P), and CT (C)-using pre-treatment [¹⁸F]FDG PET/CT scans. For comparison, we also constructed a logistic model incorporating clinical factors (clinical model). The DLS were evaluated as radiological markers for survival stratification, and nomograms for predicting survival were constructed. The models demonstrated accurate prediction of PD-L1 status. The areas under the curve (AUCs) for predicting PD-L1 status were as follows: CPC (0.927), PC (0.904), P (0.886), C (0.934), and the clinical model (0.603) in the training cohort; CPC (0.882), PC (0.848), P (0.770), C (0.745), and the clinical model (0.524) in the internal validation cohort; and CPC (0.843), PC (0.806), P (0.759), C (0.667), and the clinical model (0.671) in the external validation cohort. The CPC and PC models exhibited superior predictive performance. Survival analysis revealed that the DLS from most models effectively stratified overall survival and progression-free survival at appropriate cut-off points (P < 0.05), outperforming stratification based on PD-L1 status (combined positive score ≥ 10). Furthermore, incorporating model scores with clinical factors in nomograms enhanced the predictive probability of survival after immunotherapy. Deep learning models based on [¹⁸F]FDG PET/CT can accurately predict PD-L1 status in esophageal cancer patients. The derived DLS can effectively stratify survival outcomes following immunotherapy, particularly when combined with clinical factors.

Segmenting liver tumors in medical imaging is pivotal for precise diagnosis, treatment, and evaluating therapy outcomes. Even with modern imaging technologies, fully automated segmentation systems have not overcome the challenge posed by the diversity in the shape, size, and texture of liver tumors. Such delays often hinder clinicians from making timely and accurate decisions. This study tries to resolve these issues with the development of UIGO. This new deep learning model merges U-Net and Inception networks, incorporating advanced feature selection and optimization strategies. The goals of UIGO include achieving high precision segmented results while maintaining optimal computational requirements for efficiency in real-world clinical use. Publicly available liver tumor segmentation datasets were used for testing the model: LiTS (Liver Tumor Segmentation Challenge), CHAOS (Combined Healthy Abdominal Organ Segmentation), and 3D-IRCADb1 (3D-IRCAD liver dataset). With various tumor shapes and sizes ranging across different imaging modalities such as CT and MRI, these datasets ensured comprehensive testing of UIGO's performance in diverse clinical scenarios. The experimental outcomes show the effectiveness of UIGO with a segmentation accuracy of 99.93%, an AUC score of 99.89%, a Dice Coefficient of 0.997, and an IoU of 0.998. UIGO demonstrated higher performance than other contemporary liver tumor segmentation techniques, indicating the system's ability to enhance clinician's ability to deliver precise and prompt evaluations at a lower computational expense. This study underscores the effort towards advanced streamlined, dependable, and clinically useful devices for liver tumor segmentation in medical imaging.

This study investigates the use of CT-based radiomics for predicting extrahepatic metastasis in hepatocellular carcinoma (HCC) following hepatectomy. We analyzed data from 374 patients from two centers (277 in the training cohort and 97 in an external validation cohort). Radiomic features were extracted from contrast-enhanced CT scans. Key features were identified using the least absolute shrinkage and selection operator (LASSO) to compute radiomics scores (radscore) for model development. A clinical model based on risk factors was also created. We developed a combined model integrating both radscore and clinical variables, constructing nomograms for personalized risk assessment. Model performance was compared via the Delong test, with calibration curves assessing prediction consistency. Decision curve analysis (DCA) was employed to assess the clinical utility and net benefit of the predictive models across different threshold probabilities, thereby evaluating their potential value in guiding clinical decision-making for extrahepatic metastasis. Radscore based on CT was an independent predictor of extrahepatic disease (p < 0.05). The combined model showed high predictive performance with an AUC of 87.2% (95% CI: 81.8%-92.6%) in the training group and 86.0% (95% CI: 69.4%-100%) in the validation group. Predictive performance of the combined model significantly outperformed both the radiomics and clinical models (p < 0.05). The DCA shows that the combined model has a higher net benefit in predicting extrahepatic metastases of HCC than the clinical model and radiomics model. The combined prediction model, utilizing CT radscore alongside clinical risk factors, effectively forecasts extrahepatic metastasis in HCC patients.

Thyroid cancer is one of the most common endocrine malignancies. Its incidence has steadily increased in recent years. Distinguishing between benign and malignant thyroid nodules (TNs) is challenging due to their overlapping imaging features. The rapid advancement of artificial intelligence (AI) in medical image analysis, particularly deep learning (DL) algorithms, has provided novel solutions for automated TN detection. However, existing studies exhibit substantial heterogeneity in diagnostic performance. Furthermore, no systematic evidence-based research comprehensively assesses the diagnostic performance of DL models in this field. This study aimed to execute a systematic review and meta-analysis to appraise the performance of DL algorithms in diagnosing TN malignancy, identify key factors influencing their diagnostic efficacy, and compare their accuracy with that of clinicians in image-based diagnosis. We systematically searched multiple databases, including PubMed, Cochrane, Embase, Web of Science, and IEEE, and identified 41 eligible studies for systematic review and meta-analysis. Based on the task type, studies were categorized into segmentation (n=14) and detection (n=27) tasks. The pooled sensitivity, specificity, and the area under the receiver operating characteristic curve (AUC) were calculated for each group. Subgroup analyses were performed to examine the impact of transfer learning and compare model performance against clinicians. For segmentation tasks, the pooled sensitivity, specificity, and AUC were 82% (95% CI 79%-84%), 95% (95% CI 92%-96%), and 0.91 (95% CI 0.89-0.94), respectively. For detection tasks, the pooled sensitivity, specificity, and AUC were 91% (95% CI 89%-93%), 89% (95% CI 86%-91%), and 0.96 (95% CI 0.93-0.97), respectively. Some studies demonstrated that DL models could achieve diagnostic performance comparable with, or even exceeding, that of clinicians in certain scenarios. The application of transfer learning contributed to improved model performance. DL algorithms exhibit promising diagnostic accuracy in TN imaging, highlighting their potential as auxiliary diagnostic tools. However, current studies are limited by suboptimal methodological design, inconsistent image quality across datasets, and insufficient external validation, which may introduce bias. Future research should enhance methodological standardization, improve model interpretability, and promote transparent reporting to facilitate the sustainable clinical translation of DL-based solutions.

Despite academic success, radiomics-based machine learning algorithms have not reached clinical practice, partially due to limited repeatability/reproducibility. To address this issue, this work aims to identify a stable subset of radiomics features in prostate MRI for radiomics modelling. A prospective study was conducted in 43 patients who received a clinical MRI examination and a research exam with repetition of T2-weighted and two different diffusion-weighted imaging (DWI) sequences with repositioning in between. Radiomics feature (RF) extraction was performed from MRI segmentations accounting for intra-rater and inter-rater effects, and three different image normalization methods were compared. Stability of RFs was assessed using the concordance correlation coefficient (CCC) for different comparisons: rater effects, inter-scan (before and after repositioning) and inter-sequence (between the two diffusion-weighted sequences) variability. In total, only 64 out of 321 (~ 20%) extracted features demonstrated stability, defined as CCC ≥ 0.75 in all settings (5 high-b value, 7 ADC- and 52 T2-derived features). For DWI, primarily intensity-based features proved stable with no shape feature passing the CCC threshold. T2-weighted images possessed the largest number of stable features with multiple shape (7), intensity-based (7) and texture features (28). Z-score normalization for high-b value images and muscle-normalization for T2-weighted images were identified as suitable.

To develop a CT-based deep learning radiomics nomogram (DLRN) for the preoperative prediction of peritoneal metastasis (PM) in patients with ovarian cancer (OC). A total of 296 patients with OCs were randomly divided into training dataset (N = 207) and test dataset (N = 89). The radiomics features and DL features were extracted from CT images of each patient. Specifically, radiomics features were extracted from the 3D tumor regions, while DL features were extracted from the 2D slice with the largest tumor region of interest (ROI). The least absolute shrinkage and selection operator (LASSO) algorithm was used to select radiomics and DL features, and the radiomics score (Radscore) and DL score (Deepscore) were calculated. Multivariate logistic regression was employed to construct clinical model. The important clinical factors, radiomics and DL features were integrated to build the DLRN. The predictive performance of the models was evaluated using the area under the receiver operating characteristic curve (AUC) and DeLong's test. Nine radiomics features and 10 DL features were selected. Carbohydrate antigen 125 (CA-125) was the independent clinical predictor. In the training dataset, the AUC values of the clinical, radiomics and DL models were 0.618, 0.842, and 0.860, respectively. In the test dataset, the AUC values of these models were 0.591, 0.819 and 0.917, respectively. The DLRN showed better performance than other models in both training and test datasets with AUCs of 0.943 and 0.951, respectively. Decision curve analysis and calibration curve showed that the DLRN provided relatively high clinical benefit in both the training and test datasets. The DLRN demonstrated superior performance in predicting preoperative PM in patients with OC. This model offers a highly accurate and noninvasive tool for preoperative prediction, with substantial clinical potential to provide critical information for individualized treatment planning, thereby enabling more precise and effective management of OC patients.

Prostate MRI has traditionally relied on qualitative interpretation. However, quantitative components hold the potential to markedly improve performance. The ADC from DWI is probably the most widely recognized quantitative MRI biomarker and has shown strong discriminatory value for clinically significant prostate cancer as well as for recurrent cancer after treatment. Advanced diffusion techniques, including intravoxel incoherent motion imaging, diffusion kurtosis imaging, diffusion-tensor imaging, and specific implementations such as restriction spectrum imaging, purport even better discrimination but are more technically challenging. The inherent T1 and T2 of tissue also provide diagnostic value, with more advanced techniques deriving luminal water fraction and hybrid multidimensional MRI metrics. Dynamic contrast-enhanced imaging, primarily using a modified Tofts model, also shows independent discriminatory value. Finally, quantitative lesion size and shape features can be combined with the aforementioned techniques and can be further refined using radiomics, texture analysis, and artificial intelligence. Which technique will ultimately find widespread clinical use will depend on validation across a myriad of platforms and use cases.

Purpose: Prenatal ultrasound is a key tool in evaluating fetal structural development and detecting abnormalities, contributing to reduced perinatal complications and improved neonatal survival. Accurate identification of standard fetal torso planes is essential for reliable assessment and personalized prenatal care. However, limitations such as low contrast and unclear texture details in ultrasound imaging pose significant challenges for fine-grained anatomical recognition. Methods: We propose a novel Multi-Contrast Fusion Module (MCFM) to enhance the model's ability to extract detailed information from ultrasound images. MCFM operates exclusively on the lower layers of the neural network, directly processing raw ultrasound data. By assigning attention weights to image representations under different contrast conditions, the module enhances feature modeling while explicitly maintaining minimal parameter overhead. Results: The proposed MCFM was evaluated on a curated dataset of fetal torso plane ultrasound images. Experimental results demonstrate that MCFM substantially improves recognition performance, with a minimal increase in model complexity. The integration of multi-contrast attention enables the model to better capture subtle anatomical structures, contributing to higher classification accuracy and clinical reliability. Conclusions: Our method provides an effective solution for improving fetal torso plane recognition in ultrasound imaging. By enhancing feature representation through multi-contrast fusion, the proposed approach supports clinicians in achieving more accurate and consistent diagnoses, demonstrating strong potential for clinical adoption in prenatal screening. The codes are available at https://github.com/sysll/MCFM.

Accurate segmentation of thyroid nodules in ultrasound images is critical for clinical diagnosis but remains challenging due to low contrast and complex anatomical structures. Existing deep learning methods often rely solely on local nodule features, lacking anatomical prior knowledge of the thyroid region, which can result in misclassification of non-thyroid tissues, especially in low-quality scans. To address these issues, we propose a Spatial Prior-Guided Dual-Path Network that integrates a prior-aware encoder to model thyroid anatomical structures and a low-cost heterogeneous encoder to preserve fine-grained multi-scale features, enhancing both spatial detail and contextual awareness. To capture the diverse and irregular appearances of nodules, we design a CrossBlock module, which combines an efficient cross-attention mechanism with mixed-scale convolutional operations to enable global context modeling and local feature extraction. The network further employs a dual-decoder architecture, where one decoder learns thyroid region priors and the other focuses on accurate nodule segmentation. Gland-specific features are hierarchically refined and injected into the nodule decoder to enhance boundary delineation through anatomical guidance. Extensive experiments on the TN3K and MTNS datasets demonstrate that our method consistently outperforms state-of-the-art approaches, particularly in boundary precision and localization accuracy, offering practical value for preoperative planning and clinical decision-making.